Literature DB >> 25399001

Reply to "Helicobacter pylori vacA as marker for gastric cancer and gastroduodenal diseases: one but not the only factor".

Ameer A Memon1, John C Atherton2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25399001      PMCID： PMC4313328          DOI： 10.1128/JCM.02667-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  vacA i-region subtyping.

Authors:  Hiroaki Ogiwara; David Y Graham; Yoshio Yamaoka
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

2.  Helicobacter pylori vacA as marker for gastric cancer and gastroduodenal diseases: one but not the only factor.

Authors:  Amin Talebi Bezmin Abadi; Yeong Yeh Lee
Journal:  J Clin Microbiol       Date:  2014-12       Impact factor: 5.948

3.  Vacuolating cytotoxin genotypes are strong markers of gastric cancer and duodenal ulcer-associated Helicobacter pylori strains: a matched case-control study.

Authors:  Ameer A Memon; Nawfal R Hussein; Véronique Y Miendje Deyi; Alain Burette; John C Atherton
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

4.  A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer.

Authors:  Joanne L Rhead; Darren P Letley; Marjan Mohammadi; Nawfal Hussein; Mohammad A Mohagheghi; Mahmoud Eshagh Hosseini; John C Atherton
Journal:  Gastroenterology       Date:  2007-07-03       Impact factor: 22.682

5.  Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms.

Authors:  Daniela Basso; Carlo-Federico Zambon; Darren P Letley; Alessia Stranges; Alberto Marchet; Joanne L Rhead; Stefania Schiavon; Graziella Guariso; Marco Ceroti; Donato Nitti; Massimo Rugge; Mario Plebani; John C Atherton
Journal:  Gastroenterology       Date:  2008-03-25       Impact factor: 22.682
  5 in total
  1 in total

Review 1.  Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy.

Authors:  Farnaz Fahimi; Mohammad Reza Tohidkia; Mehdi Fouladi; Reza Aghabeygi; Naser Samadi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2017-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.